Serialized Labeling (51662 1547 1 Serialized Labeling)
Vecuronium Bromide Injection, Powder, Lyophilized, For Solution
Product Images NDC 51662-1547
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vecuronium Bromide (NDC 51662-1547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Boxed Warning (Boxed Warning)
This text is a warning about a drug and advises that it should only be administered by people who are well-trained and familiar with its actions, characteristics, and potential hazards.*
Dosage (Dosage)
This text describes the individualization of the drug delivery rate of Vecuronium Bromide using an infusion pump with a table that provides for the amount of drug delivery rate and infusion delivery rate for different patient weights and drug concentrations. The table mentions the rate of mL/min for a solution of 0.1 ma/m (10 mg in 100 mL). It also contains a note that if the concentration of the drug is halved, the rate should be decreased by one-half.*
Structure (Structure)
Not available. The text is too short and lacks context to generate a useful description.*
Vial Labeling (Vial Label)
This is a warning label for Vecuronium, also known as Bromide. It is a paralyzing agent that can cause respiratory failure, and facilities must have artificial respiration immediately available. The dosage and storage instructions are found in the package insert, and it should be protected from light. There is a warning that it contains benzyl alcohol and should not be used in newborns. It can be reconstituted with bacteriostatic water or sterile water compatible with the solutions listed in the package insert, and it is for intravenous use only. The package contains 10 mg of the drug in a single-use vial, and any unused portion should be discarded within 24 hours. The drug is distributed by AuroMedics Pharma LLC from E. Windsor, NJ and is made in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
